Terms: = Breast cancer AND DEK, D6S231E, 7913, ENSG00000124795, P35659 AND Prognosis
6 results:
1. dek oncoprotein participates in heterochromatin replication via SUMO-dependent nuclear bodies.
Pierzynska-Mach A; Czada C; Vogel C; Gwosch E; Osswald X; Bartoschek D; Diaspro A; Kappes F; Ferrando-May E
J Cell Sci; 2023 Dec; 136(23):. PubMed ID: 37997922
[TBL] [Abstract] [Full Text] [Related]
2. Role of dek in carcinogenesis, diagnosis, prognosis, and therapeutic outcome of breast cancer: An evidence-based clinical review.
Habiburrahman M; Sutopo S; Wardoyo MP
Crit Rev Oncol Hematol; 2023 Jan; 181():103897. PubMed ID: 36535490
[TBL] [Abstract] [Full Text] [Related]
3. Optical Redox Imaging Detects the Effects of dek Oncogene Knockdown on the Redox State of MDA-MB-231 breast cancer Cells.
Wen Y; Xu HN; Privette Vinnedge L; Feng M; Li LZ
Mol Imaging Biol; 2019 Jun; 21(3):410-416. PubMed ID: 30758703
[TBL] [Abstract] [Full Text] [Related]
4. The unique dek oncoprotein in women's health: A potential novel biomarker.
de Albuquerque Oliveira AC; Kappes F; Martins DBG; de Lima Filho JL
Biomed Pharmacother; 2018 Oct; 106():142-148. PubMed ID: 29957464
[TBL] [Abstract] [Full Text] [Related]
5. dek: A novel early screening and prognostic marker for breast cancer.
Ying G; Wu Y
Mol Med Rep; 2015 Nov; 12(5):7491-5. PubMed ID: 26459608
[TBL] [Abstract] [Full Text] [Related]
6. The dek oncogene is a target of steroid hormone receptor signaling in breast cancer.
Privette Vinnedge LM; Ho SM; Wikenheiser-Brokamp KA; Wells SI
PLoS One; 2012; 7(10):e46985. PubMed ID: 23071688
[TBL] [Abstract] [Full Text] [Related]
